DARTFORD, UK – 27 JULY 2020
Caligor Coghlan Pharma Services (CCPS), a premier, global provider of pharma services, today announced the appointment of Angela Bonich as Director of Business Development for the company’s Early Access to Medicines and, newly formed, Strategic Services business lines. Ms. Bonich is based in the UK, and she will be responsible for developing new business opportunities for early and expanded access to medicines, unlicensed medicines, and regulatory consulting services.
Ms. Bonich, a 20 year industry veteran, has been selling products, services and consultancy across a broad range of industry sectors, including full service CRO services, manufacturing, packaging, logistics, clinical trial management, volunteer and patient recruitment, regulatory affairs, pharmacovigilance, data management, statistics, software systems and early development consultancy services including CMC, PK analysis and clinical pharmacology. Ms. Bonich joins CCPS from Venn Life Sciences, where she had responsibility for new business development and account management with clients across Europe and the USA.
“When CCPS expanded its portfolio to provide regulatory and consulting services last year, I knew an experienced business development lead was needed to promote our continued growth in the European markets,” said Geoff Fatzinger, Managing Director UK/Global Vice President of Strategic Services and Early Access to Medicines at CCPS. “With Angela’s proven track record of success and industry experience, she will help CCPS meet the needs of our clients and their patients.”
About Caligor Coghlan Pharma Services
Caligor Coghlan Pharma Services is global provider of pharma services to assist in the development to commercialization of pharmaceutical, biotechnology, and medical device assets. Services include clinical trial design, clinical packaging and labeling, IMP management and distribution, comparator and ancillary procurement, Clinical Supply Management, Early Access to Medicines services, global Regulatory consulting, commercialized product distribution, and asset acquisition planning. The company operates facilities in Bastrop, TX, USA, and Dartford, UK, and maintains a global network of depots to ensure rapid and timely delivery of therapeutics and supplies to patients and physicians globally. www.calcog.com
Vice President of Commercial